Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 15715

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.03, p 0.946). This receipt's hash covers every field on it, plus the hash of receipt 15714, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 15715
    31 Oct 2026, 01:54 UTC


    BCAR1

    oligodendrocytes, braak


    predictionBCAR1 in oligodendrocytes tracks Braak Lewy-body stage

    registered11eceffa8324392d

    discovery-0.03 p=0.946 n=9

    replication-0.33 p=0.385 n=9

    neededp < 0.05 twice, same sign


    no effect in discovery (spearman rho -0.03, p 0.946)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    9b780bc04d813ed697e55e1c…
    follows 3df51895fd79…

Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next

The swarm's case

receipt 15715: BCAR1 in oligodendrocytes, braak

power
full sample -0.13 (p 0.609, n 18), 95% CI -0.56 to +0.36. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.15 (p 0.561, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.16 (p 0.532, n 18). could be the mix.
skeptic
leave-one-out range -0.29 to -0.07, sign flips 0; without severely affected donors -0.13 (p 0.609, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for BCAR1 in oligodendrocytes.

case closed: nothing better to follow up.